Browsing ICR Divisions by subject "Vascular Endothelial Growth Factors"
Now showing items 1-1 of 1
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab. (2016-10)<h4>Background</h4>Angiogenesis inhibition is an important strategy for cancer treatment. Ramucirumab, a human IgG1 monoclonal antibody that targets VEGF receptor 2 (VEGFR2), inhibits VEGF-A, -C, -D binding and endothelial ...